Often, medicinal discovery has focused on minute compounds, but peptide partners are progressively demonstrating traction. This innovative strategy involves combining peptidic sequences with other biological modalities to address intricate illness pathways. By leveraging the specific properties of peptides – such as high specificity and delivery